CIK 0001818331 · Large accelerated filer
GeneDx Holdings Corp.
Sign in to watch- Ticker
- WGS
- Exchange
- Nasdaq
- Industry
- Services-Health Services
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851966622
- Phone
- 888-729-1206
- Business address
- 333 LUDLOW STREET, NORTH TOWER, 6TH FLOOR, STAMFORD, CT, 06902
- Former names
- Sema4 Holdings Corp., CM Life Sciences, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,839,245
- in 5 filings
Net −$1,839,245. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −366 | $140.08 | $51K | 12,089 |
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −951 | $141.20 | $134K | 11,138 |
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −215 | $142.12 | $31K | 10,923 |
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −334 | $144.27 | $48K | 10,589 |
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −578 | $145.36 | $84K | 10,011 |
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −699 | $146.93 | $103K | 9,312 |
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −331 | $148.55 | $49K | 8,981 |
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −97 | $149.20 | $14K | 8,884 |
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −26 | $150.75 | $4K | 8,858 |
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Sale | −127 | $140.45 | $18K | 8,731 |
| 2025-12-16 | Feeley Kevin CHIEF FINANCIAL OFFICER | Option exercise · Restricted Stock Unit | −7,197 | 35,984 | ||
| 2025-12-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Option exercise | +18,750 | 25,094 | ||
| 2025-12-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −369 | $138.93 | $51K | 24,725 |
| 2025-12-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −1,031 | $140.08 | $144K | 23,694 |
| 2025-12-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −2,679 | $141.20 | $378K | 21,015 |
| 2025-12-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −604 | $142.12 | $86K | 20,411 |
| 2025-12-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −940 | $144.27 | $136K | 19,471 |
| 2025-12-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −1,628 | $145.36 | $237K | 17,843 |
| 2025-12-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −1,970 | $146.93 | $289K | 15,873 |
| 2025-12-16 | Stueland Katherine CHIEF EXECUTIVE OFFICER | Sale | −932 | $148.55 | $138K | 14,941 |
Page 10 of 23 · 450 trades